Albanian Association of Thalassaemia and other Haemoglobinopathies

  • Home
  • Albania
  • Tirana
  • Albanian Association of Thalassaemia and other Haemoglobinopathies

Albanian Association of Thalassaemia and other Haemoglobinopathies Because of this, also their needs have increased even more in terms of medical care and social involvement. b. c. Social involvement of patients. d.

”Albanian Association of Thalassaemia and other Haemoglobinopathies” is a patient’s association created with the mission to ensure qualitative and equal treatment for all patients with Thalassemia and other Haemoglobinopathies in Albania. In the last two decades thanks to new therapies and to new diagnostical methods, life expectancy has increased for patients with thalassemia in Albania as in other countries all over the world. Nowadays thalassemia patients due to regular treatment can have a normal life, being able to assume important positions in social and professional life (such as accouters, journalist, doctors, nurses etc.) This is the main reason we have decided to found this association, which is based in the following principles:
a. Participation in health policy, social policy, prevention policy, and blood donation policy. Improving the quality of medical care and recognition of the rights of the patient. Creation and development of a network of cooperation with other associations within and outside the country.

“Shoqata Shqiptare e Thalassaemisë dhe Haemoglobinopathive të tjera” është një shoqatë pacientësh e formuar me misionin për të siguruar trajtim cilësor dhe të barabartë për të tërë pacientët me Thalassaemi dhe Hemoglobinopathi në tërë territorin shqiptar. Në dy dekadat e fundit, në saj të futjes së terapive të reja dhe metodave të reja diagnostikuese, jetëgjatësia e pacientëve me Talasemi në vendin tonë ashtu si edhe në Botë është rritur ndjeshëm. Sot, pacientët me talasemi, në sajë të trajtimit të rregullt mjeksor, mund të kryejnë një jetë normale, duke zënë pozicione të rëndësishme sociale dhe profesionale (ekonomistë, gazetarë, mjekë, infermjerë etj.) Nga ana tjetër kjo ka bërë që nevojat e tyre të jenë gjithnjë e më në rritje, si në aspektin e kujdesit shëndetsor ashtu edhe në integrimin social të tyre. Kjo është arsyeja kryesore për formimin e kësaj shoqate, e cila mbështetet në parimet e mëposhtme:
a. Pjesëmarrja në politikat shëndetsore, sociale, në politikat e parandalimit dhe dhurimit të gjakut. Përmirsimi i cilësisë së shërbimit shëndetsor, njohja e të drejtave të pacientit dhe edukimi shëndetsor për pacientet. Integrimi social i pacientëve. Krijimi dhe zhvillimi i një rrjeti bashkëpunimi me shoqatat e tjera brenda dhe jashtë vendit.

25/04/2025

Warrior! 💪🏼🏃🏻‍♀️

International Thalassaemia Day 2022 -Official Global Press Release On International Thalassaemia Day, the Thalassaemia I...
26/04/2022

International Thalassaemia Day 2022 -
Official Global Press Release

On International Thalassaemia Day, the Thalassaemia International Federation (TIF) unites the global haemoglobin disorders community, by raising awareness, sharing knowledge and bringing thalassaemia to the attention of as many people as possible worldwide.
NICOSIA, April 26, 2022 / Thalassaemia International Federation (TIF) - This International Thalassaemia Day, 8 May 2022, we recognize and celebrate the power of knowledge. The International Thalassaemia Day (ITD) 2022 theme, “Be Aware. Share. Care: Working with the global community as one to improve thalassaemia knowledge”, is an open call to action to all supporters to promote awareness about thalassaemia and its global impact and share essential information and knowledge to support the best possible health, social and other care of people affected by this disease.

With this core message, the global campaign conducted by TIF for the 18th consecutive year underscores the value of each individual contribution to reducing the prevalence of thalassaemia, whilst stressing that collective action towards enhancing awareness and understanding of the condition is crucial for its effective treatment.

‘’Despite the ‘spread’ of thalassaemia at an increasing rate worldwide, public awareness and information about the condition, in addition to concrete and tangible actions by competent healthcare authorities at the local level towards its effective prevention, control and management, remain significantly limited in many countries. Today we call for the intensification of concerted efforts and collective mobilization by all related stakeholders to change that’’, affirmed Dr Androulla Eleftheriou, TIF Executive Director.

It is indeed noteworthy that 8 out of 10 people with thalassaemia across the world are unaware that they have the mutated gene that causes the disease and that they could have a child with a severe form of thalassaemia, if their partner is also a carrier of the disease. As a result, more than half a million children are expected to be born with thalassaemia and other haemoglobin disorders worldwide by 2030[1].

‘’Improving awareness is the first, critical step to any kind of change. Although its value has been jointly recognized by governments, civil societies and healthcare professionals alike as a key component of sensitization towards thalassaemia, we need to do more to achieve greater understanding of this serious and potentially debilitating genetic blood condition and to allow the establishment and strengthening of disease-specific, patient-centred policies for better health, social inclusion and quality of life of affected individuals and their families’’, added Mr Panos Englezos, TIF President.

In celebration of the ITD2022 and seeking to reiterate that thalassaemia awareness and control must become a priority in public health at national, regional and global scales, TIF has launched a massive online campaign with rich communication and informational resources to disseminate the messages and useful information of the "Be Aware. Share. Care" theme, and to foster the active participation of all supporters.

Moreover, the Federation has developed 4 brochures that explain in a simple and comprehensive way a wide range of topics pertaining to the disease. This material has been made available for the first time in the history of TIF’s work, in more than 20 languages in an effort to reach out to as many individuals, stakeholders and NGOs as possible from all over the world and provide them with valuable insights into thalassaemia diagnosis, prevention, treatment, and research.

The International Thalassaemia Day 2022 will be observed in over 110 countries across the globe, where a multitude of awareness-raising events, blood drives, educational activities, scientific meetings, etc. will take place. TIF will actively join initiatives organised in Italy, India, Brazil, Greece, Egypt and Turkey.

Scientific advances for better care, quality of life, and even cure of patients with thalassaemia are at our doorstep and we all need to work towards making them accessible and available to our patients!

To learn more about International Thalassaemia Day, please visit https://thalassaemia.org.cy/itd2022/

📚Libri më i mirë për njerëzit që duan të mësojnë se çfarë është e rëndësishme që një person të jetë i shëndetshëm. (Çfar...
22/03/2022

📚Libri më i mirë për njerëzit që duan të mësojnë se çfarë është e rëndësishme që një person të jetë i shëndetshëm. (Çfarë të hani, palestra etj!

🇬🇧The best book for people who want to learn what is important for a person to be healthy. (What to eat, fitness)

WELCOME. WE ARE HAPPY THAT YOU ARE HERE. . .

💪Zbuloni sekretin e Himalajës për të shpëtuar nga dhimbjet e shpinës!🇬🇧Himalayan back pain secret revealed for the first...
22/03/2022

💪Zbuloni sekretin e Himalajës për të shpëtuar nga dhimbjet e shpinës!

🇬🇧Himalayan back pain secret revealed for the first time!

Back Pain SOS is designed so that once you have it in your hands, you could say goodbye to back pain forever... right in the comfort of your own home...

12/04/2021

Minor side effects are a normal sign that the immune system is mounting a protective response following vaccination, although they aren’t universal.

🙏🏼🥰
01/02/2021

🙏🏼🥰

Kryefaqja Aktualitet Universitetet ndërgjegjësohen, nis dhurimi i gjakut për pacientët me talasemi AktualitetCovid-19 Universitetet ndërgjegjësohen, nis dhurimi i gjakut për pacientët me talasemi February 1, 2021 0 Shpërndaje Facebook Twitter Për të sëmurët me talesemi e vetmja mënyrë...

21/01/2021

Një shembull i mrekullueshëm nga nje Zonje e mrekullueshme. Faleminderit Zonja Ambasadore! 💖 Embassy of Sweden in Tirana

Ju ftojme te gjitheve te dhuroni ne keto kohe te veshtira. Gjaku eshte jete dhe cdo pike eshte me vlere!
12/08/2020

Ju ftojme te gjitheve te dhuroni ne keto kohe te veshtira. Gjaku eshte jete dhe cdo pike eshte me vlere!

The world is faced with severe challenges relating to shortages, especially now amid the crisis.

is the only way to help whose lives are threatened by these !

Roll up your sleeves and today! It will cost you nothing, but it will save someone's life.

29/06/2020

MORE BREAKING NEWS COMING UP!!! 📢

Bristol Myers Squibb (BMS) & Acceleron Pharma Announced Today that the European Commission Approved Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent β- (TDT) in Adult . 🆗👍

Reblozyl is the first and only erythroid maturation agent approved in the , representing a new class of therapy for eligible patients. This is based on data from the pivotal Phase 3 MEDALIST and BELIEVE studies, evaluating the ability of Reblozyl to effectively address anemia associated with beta thalassemia and MDS, respectively.

“The European Commission’s approval of Reblozyl provides eligible adult with beta a new, much needed treatment option for their , and with it, the possibility of becoming less dependent on '', said Maria Domenica Cappellini, M.D., lead investigator of the BELIEVE study, Professor of Medicine, University of Milan, Fondazione IRCCS Ca Granda.

Read more: https://thalassaemia.org.cy/news/european-commission-approves-reblozyl-for-the-treatment-of-transfusion-dependent-%ce%b2-thalassaemia/

10/01/2018

The American Society of Hematology (ASH) has announced that Alexis A. Thompson, MD, MPH, has taken up the helm as its president for 2018. She will serve for a 1-year term through December 2018.

23/03/2017

Address

Tirana

Website

Alerts

Be the first to know and let us send you an email when Albanian Association of Thalassaemia and other Haemoglobinopathies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Albanian Association of Thalassaemia and other Haemoglobinopathies:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram